Summary
A series of 200 patients operated on at the Rome University Neurosurgical Clinic for primary glioblastoma is analyzed. Eight of these patients (4%) survived for over four years. The histological preparations showed more or less heavy perivascular lymphocytic infiltration in six of these cases. Since such infiltrations in malignant tumours of other organs are recognized as having an immune function, expressing the host's resistance to his tumour, the longer survival of the cases considered may well denote an immune defensive mechanism.
Similar content being viewed by others
References
Alexander, P., Fairley, G. H., Cellular resistance to tumours. Brit. Med. Bull.23 (1967), 86–92.
Brem, S., Lymphocyte infiltrates: Histological evidence of cellular immunity, in studies of the host response to a human brain tumor. Thesis. Harvard Medical School, Boston (quoted by Brem 1972).
Brem, S. S., De Tribolet, N., Dohan, F. C., Kornblith, P. L., Demonstration of cell-mediated immunity to a human brain tumor: use of anin vitro microcytotoxicity assay. Surg. Forum23 (1972), 428–430.
Brooks, W. H., Horwitz, D. A., Netsky, M. G., Evidence for tumor-specific immune response in patients with primary brain tumors. Surg. Forum23 (1972), 430–432.
Burnet, F. M., Immunological aspects of malignant disease. Lancet1 (1967), 1171–1174.
Fairley, G. H., Immunity to malignant disease in man. Brit. Med. J.2 (1969), 467–473.
Gorer, P. A., Some recent work on tumor immunity. Adv. Cancer Res.4 (1956), 149–186.
Gullotta, F., Bettag, W., Zur Frage der längeren überlebenszeit bei Glioblastomen. Acta Neurochir. (Wien)16 (1967), 122–129.
Hamlin, I. M. E., Possible host resistance in carcinoma of the breast; a histological study. Brit. J. Cancer22 (1968), 383–401.
Hellstrom, I., Hellstrom, E., Sjogren, H. O., Warner, G. A., Demonstration of cell-mediated immunity to human neoplasm of various histological types. Int. J. Cancer7 (1971), 1–16.
Jelsma, R., Bucy, P. C., The treatment of glioblastoma multiforme of the brain. J. Neurosurg.27 (1967), 388–400.
Jelsma, F., Bucy, P. C., Glioblastoma multiforme. Its treatment and some factors effecting survival. Arch. Neurol.20 (1969), 161–171.
Kornblith, P. L., Dohan, F., Wood, W. C., Whitman, B. O., Human astrocytoma: serum-mediated immunological response. Cancer33 (1974), 1512–1519.
Maccabe, J. J., Glioblastoma. In: Handbook of Clinical Neurology, Vol. 18, part 3‡ (Vinken, Bruyn, eds.). Amsterdam: North-Holland Publishing Company. 1975.
Manoury, R., Vedrenne, C., Constans, J. P., Infiltrations lymphocytaires dans les gliomes humains. Neurochirurgie3 (1975), 213–222.
Netsky, M. G., August, B., Fowler, W., The longevity of patients with glioblastoma multiforme. J. Neurosurg.7 (1950), 261–269.
Old, L. J., Boyse, E. A., Immunity of experimental tumor. A. Rev. Med.15 (1964), 167–186.
Peserico, L., Granulomi peri-neoplastici immunocompetenti osservati nel sistema nervoso centrale con il microscopic a fluorescenza. Giorn. Psich. Neuropat.3 (1968), 466–472.
Ridley, A., Antilymphocytic serum and tumor transplantation in the brain. Acta Neuropath.19 (1971), 307–317.
Riddley, A., Cavanagh, J. B., Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brain94 (1971), 117–124.
Roth, J. G., Elvidge, A. R., Glioblastoma multiforme: a clinical survey. J. Neurosurg.17 (1960), 736–750.
Russel, D. S., Rubinstein, L. J., The pathology of tumors of the nervous system. London: Arnold. 1959.
Scheinberg, L. C., Edelman, F., Levy, A., Is the brain an “Immunologically privileged site”? Studies based on intracerebral tumor homotransplantation and isotransplantation to sensitized hosts. Arch. Neurol.11 (1964) 248–264.
Scheinberg, L. C., Levy, A., Edelman, F., Its the brain an “Immunologically privileged site?” Studies in induced host resistance to transplantable mouse glioma following irradiation of prior implants. Arch. Neurol.13 (1965), 283–286.
Scherer, H. J., The forms of growth in glioma and their practical significance. Brain68 (1940), 1–36.
Scherer, J. H., Cerebral astrocytomas and their derivatives. Amer. J. Cancer40 (1940), 159–198.
Schettler, T., Shealy, C. N., Experimental selective alteration of blood-barrier by X-irradiation. J. Neurosurg.32 (1970), 89–94.
Schiffer, D., Fabiani, A., Patologia dei tumori cerebrali. Roma: Il Pensiero Scientifico. 1970.
Schiffer, D., Croveri, G., Pautasso, C., Frequenza e significato degli infiltrati linfoplasmacellulari nei gliomi umani. Tumori60 (1974), 177–184.
Sjogren, H. O., Hellstrom, I., Bausal, S. C., Warner, G. A., Hellstrom, K. E., Elution of blocking factors from human tumors, capable of abrogating tumorcell destruction by specifically immune lymphocytes. Int. J. Cancer9 (1972), 274–283.
Stewart, T. H. M., The presence of delayed hypersensivity reactions in patients toward cellular extracts of their malignant tumors. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a discussion of the significance of this phenomenon. Cancer23 (1969), 1380–1387.
Trouillas, P., Lapras, C., Immunothérapie active des tumeurs cérébrales. A propos de 20 cas. Neurochirurgie16 (1977, 143–170.
Wahlstrom, F., Saksela, E., Troupp, H., Cell-bound antiglial immunity in patients with malignant tumor of the brain. Cell. Immunol.6 (1973), 161–170.
Zülch, K. J., Tumori cerebrali: biologia e patologia. Padova: Piccin Editore. 1974.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Di Lorenzo, N., Palma, L. & Nicole, S. Lymphocytic infiltration in long-survival glioblastomas: Possible host's resistance. Acta neurochir 39, 27–33 (1977). https://doi.org/10.1007/BF01405238
Issue Date:
DOI: https://doi.org/10.1007/BF01405238